Zymergen Inc. (ZY) ist ein börsennotiertes Unternehmen im Grundstoffe Sektor, tätig in der Chemicals - Specialty Branche. Der Hauptsitz des Unternehmens ist in EmeryVille, CA, United States. Der aktuelle CEO ist Joshua J. Hoffmann.
ZY hat IPO-Datum 2021-04-22, 502 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
